ロート製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/04/01 | 3,650 | 3,675 | 3,590 | 3,660 | -35 | -0.9% | 292,000 |
2022/03/31 | 3,755 | 3,775 | 3,685 | 3,695 | -75 | -2% | 292,400 |
2022/03/30 | 3,895 | 3,910 | 3,755 | 3,770 | -110 | -2.8% | 340,600 |
2022/03/29 | 3,855 | 3,895 | 3,840 | 3,880 | +35 | +0.9% | 428,100 |
2022/03/28 | 3,890 | 3,890 | 3,835 | 3,845 | -50 | -1.3% | 325,500 |
2022/03/25 | 3,945 | 3,945 | 3,860 | 3,895 | -45 | -1.1% | 329,300 |
2022/03/24 | 3,945 | 3,990 | 3,925 | 3,940 | +45 | +1.2% | 352,400 |
2022/03/23 | 3,775 | 3,905 | 3,775 | 3,895 | +135 | +3.6% | 320,700 |
2022/03/22 | 3,765 | 3,780 | 3,720 | 3,760 | +5 | +0.1% | 236,800 |
2022/03/18 | 3,785 | 3,815 | 3,700 | 3,755 | -5 | -0.1% | 437,700 |
2022/03/17 | 3,800 | 3,800 | 3,695 | 3,760 | +30 | +0.8% | 459,100 |
2022/03/16 | 3,785 | 3,790 | 3,720 | 3,730 | +10 | +0.3% | 299,900 |
2022/03/15 | 3,715 | 3,755 | 3,700 | 3,720 | +45 | +1.2% | 309,800 |
2022/03/14 | 3,720 | 3,720 | 3,645 | 3,675 | -10 | -0.3% | 185,400 |
2022/03/11 | 3,670 | 3,700 | 3,640 | 3,685 | -35 | -0.9% | 249,900 |
2022/03/10 | 3,720 | 3,735 | 3,685 | 3,720 | +95 | +2.6% | 273,000 |
2022/03/09 | 3,635 | 3,665 | 3,615 | 3,625 | -5 | -0.1% | 234,700 |
2022/03/08 | 3,670 | 3,725 | 3,610 | 3,630 | -105 | -2.8% | 349,400 |
2022/03/07 | 3,690 | 3,745 | 3,690 | 3,735 | -60 | -1.6% | 262,900 |
2022/03/04 | 3,850 | 3,860 | 3,780 | 3,795 | -50 | -1.3% | 208,900 |
2022/03/03 | 3,810 | 3,860 | 3,790 | 3,845 | +40 | +1.1% | 238,800 |
2022/03/02 | 3,725 | 3,830 | 3,720 | 3,805 | +10 | +0.3% | 231,000 |
2022/03/01 | 3,880 | 3,885 | 3,785 | 3,795 | -60 | -1.6% | 293,700 |
2022/02/28 | 3,790 | 3,870 | 3,765 | 3,855 | +105 | +2.8% | 290,300 |
2022/02/25 | 3,785 | 3,815 | 3,730 | 3,750 | -35 | -0.9% | 317,200 |
2022/02/24 | 3,730 | 3,800 | 3,715 | 3,785 | +5 | +0.1% | 344,200 |
2022/02/22 | 3,775 | 3,795 | 3,715 | 3,780 | +25 | +0.7% | 364,300 |
2022/02/21 | 3,720 | 3,765 | 3,700 | 3,755 | +5 | +0.1% | 263,300 |
2022/02/18 | 3,700 | 3,770 | 3,690 | 3,750 | +70 | +1.9% | 323,800 |
2022/02/17 | 3,605 | 3,690 | 3,605 | 3,680 | +70 | +1.9% | 327,900 |
2022/02/16 | 3,590 | 3,615 | 3,545 | 3,610 | +55 | +1.5% | 361,000 |
2022/02/15 | 3,555 | 3,630 | 3,525 | 3,555 | +110 | +3.2% | 550,500 |
2022/02/14 | 3,460 | 3,495 | 3,335 | 3,445 | +195 | +6% | 617,600 |
2022/02/10 | 3,260 | 3,260 | 3,210 | 3,250 | +20 | +0.6% | 257,700 |
2022/02/09 | 3,205 | 3,250 | 3,185 | 3,230 | +35 | +1.1% | 160,500 |
2022/02/08 | 3,225 | 3,260 | 3,190 | 3,195 | -10 | -0.3% | 156,400 |
2022/02/07 | 3,205 | 3,240 | 3,180 | 3,205 | -20 | -0.6% | 149,500 |
2022/02/04 | 3,210 | 3,245 | 3,195 | 3,225 | +15 | +0.5% | 191,000 |
2022/02/03 | 3,215 | 3,245 | 3,205 | 3,210 | -20 | -0.6% | 116,700 |
2022/02/02 | 3,150 | 3,230 | 3,150 | 3,230 | +65 | +2.1% | 131,400 |
2022/02/01 | 3,160 | 3,230 | 3,155 | 3,165 | +5 | +0.2% | 196,400 |
2022/01/31 | 3,080 | 3,170 | 3,075 | 3,160 | +15 | +0.5% | 175,200 |
2022/01/28 | 3,080 | 3,155 | 3,080 | 3,145 | +95 | +3.1% | 246,600 |
2022/01/27 | 3,180 | 3,185 | 3,030 | 3,050 | -160 | -5% | 318,100 |
2022/01/26 | 3,180 | 3,230 | 3,180 | 3,210 | +15 | +0.5% | 158,700 |
2022/01/25 | 3,180 | 3,210 | 3,135 | 3,195 | +10 | +0.3% | 173,400 |
2022/01/24 | 3,150 | 3,190 | 3,110 | 3,185 | +20 | +0.6% | 168,300 |
2022/01/21 | 3,050 | 3,180 | 3,050 | 3,165 | +55 | +1.8% | 274,900 |
2022/01/20 | 3,085 | 3,130 | 3,075 | 3,110 | ±0 | ±0% | 164,500 |
2022/01/19 | 3,150 | 3,190 | 3,095 | 3,110 | -60 | -1.9% | 266,100 |
651~
700
件表示中 / 3587件
類似銘柄と比較する
現在ご覧いただいている「ロート」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ロート | 286,200円 | +18.2% | +4.2% | 1.15% | 20.28倍 | 2.58倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
協和キリン | 250,200円 | +11.3% | -5.4% | 2.32% | 19.26倍 | 1.52倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 171,700円 | -3.5% | -50.2% | 4.66% | 13.91倍 | 1.03倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
参天薬 | 167,100円 | 0.0% | +50.6% | 2.03% | 17.81倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ペプチド | 280,900円 | +56.7% | +357.2% | 0.00% | 26.01倍 | 6.20倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム